ES419996A1 - Vaccine for neonatal calf diarrhoea - Google Patents

Vaccine for neonatal calf diarrhoea

Info

Publication number
ES419996A1
ES419996A1 ES419996A ES419996A ES419996A1 ES 419996 A1 ES419996 A1 ES 419996A1 ES 419996 A ES419996 A ES 419996A ES 419996 A ES419996 A ES 419996A ES 419996 A1 ES419996 A1 ES 419996A1
Authority
ES
Spain
Prior art keywords
virus
vaccine
neonatal calf
calf diarrhoea
diarrhoea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES419996A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska
Original Assignee
University of Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska filed Critical University of Nebraska
Publication of ES419996A1 publication Critical patent/ES419996A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method of attenuating a coronavirus calf diarrhea virus, comprising passing said virus 5 to approximately 60 times in a tissue culture that supports the growth of the virus, until the virus, when inoculated into newborn calves, prevents the development of disease after subsequent confrontation with virulent virus. (Machine-translation by Google Translate, not legally binding)
ES419996A 1972-10-30 1973-10-26 Vaccine for neonatal calf diarrhoea Expired ES419996A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30217972A 1972-10-30 1972-10-30

Publications (1)

Publication Number Publication Date
ES419996A1 true ES419996A1 (en) 1976-08-01

Family

ID=23166611

Family Applications (1)

Application Number Title Priority Date Filing Date
ES419996A Expired ES419996A1 (en) 1972-10-30 1973-10-26 Vaccine for neonatal calf diarrhoea

Country Status (17)

Country Link
JP (3) JPS5817169B2 (en)
AR (1) AR200155A1 (en)
AU (1) AU476160B2 (en)
BE (1) BE806568A (en)
CA (1) CA1019675A (en)
CH (1) CH596315A5 (en)
DD (1) DD110517A5 (en)
DE (1) DE2354324C2 (en)
ES (1) ES419996A1 (en)
FI (1) FI52740C (en)
FR (1) FR2204405B1 (en)
GB (1) GB1401565A (en)
HU (1) HU168486B (en)
IE (1) IE38423B1 (en)
NL (1) NL7314293A (en)
SE (1) SE419500B (en)
ZA (1) ZA738329B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027007U (en) * 1983-07-30 1985-02-23 株式会社　協立双葉自動機 Labeling machine with container rotation speed adjustment device
JPH0518338Y2 (en) * 1985-12-27 1993-05-17
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine
GB8818415D0 (en) * 1988-08-03 1988-09-07 Animal Health Inst Vaccine
JPH08786B2 (en) * 1993-02-25 1996-01-10 株式会社微生物化学研究所 Bovine coronavirus infectious disease vaccine
EP3372677B8 (en) 2015-11-06 2019-09-25 Asahi Kasei Medical Co., Ltd. Method for producing parvovirus having high infectivity titer and high purity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759425A (en) * 1969-11-28 1971-05-25 Mebus Charles A CALVES DIARRHEA VACCINES, THEIR PREPARATION AND USE
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same

Also Published As

Publication number Publication date
AU476160B2 (en) 1976-09-16
IE38423L (en) 1974-04-30
CA1019675A (en) 1977-10-25
DE2354324A1 (en) 1974-05-09
GB1401565A (en) 1975-07-16
FR2204405A1 (en) 1974-05-24
AU6177473A (en) 1975-04-24
JPS5531058A (en) 1980-03-05
JPS6124370B2 (en) 1986-06-10
CH596315A5 (en) 1978-03-15
JPS5757449B2 (en) 1982-12-04
BE806568A (en) 1974-04-26
JPS5817169B2 (en) 1983-04-05
IE38423B1 (en) 1978-03-15
FR2204405B1 (en) 1977-01-28
JPS4980230A (en) 1974-08-02
DD110517A5 (en) 1974-12-20
HU168486B (en) 1976-05-28
DE2354324C2 (en) 1982-06-03
JPS57131726A (en) 1982-08-14
NL7314293A (en) 1974-05-02
FI52740B (en) 1977-08-01
AR200155A1 (en) 1974-10-24
FI52740C (en) 1977-11-10
ZA738329B (en) 1974-09-25
SE419500B (en) 1981-08-10

Similar Documents

Publication Publication Date Title
ES538588A0 (en) A PROCEDURE FOR OBTAINING A CANINE CORONAVIRUS VACCINE
ES303092A1 (en) Apparatus for the correction of the problems of the movement of the language. (Machine-translation by Google Translate, not legally binding)
SE7512828L (en) CALICIVIRUSVACCIN
ES419996A1 (en) Vaccine for neonatal calf diarrhoea
BE866464A (en) ADVANCED ACELLULAR VACCINES CONTAINING CAPSULAR POLYSACCHARIDES.
ES258463A1 (en) Trivalent poliomyelitis live virus vaccine
ES446637A1 (en) Acellular vaccines
ES300682A1 (en) Procedure for the preparation of foods favored for the development of the animals of breeding (Machine-translation by Google Translate, not legally binding)
ES394860A1 (en) Process for the manufacture of a live vaccine against the infectious bursitis of chickens
ES260718A1 (en) Procedure for the obtaining of a vaccine against the contagious fever of dogs (febris contagiosa canum) (Machine-translation by Google Translate, not legally binding)
ES306989A1 (en) Procedure for the production of a composition of veterinary vaccines. (Machine-translation by Google Translate, not legally binding)
ES389874A1 (en) Apparatus for sterilizing compressed air
ES428370A1 (en) Vaccine for marek's disease of poultry
ES279927A1 (en) Procedure for the preparation of a vaccine against foot-and-mouth disease (Machine-translation by Google Translate, not legally binding)
ES255146A3 (en) Method of preparation of effective immunizing antigens in vaccination of cattle (Machine-translation by Google Translate, not legally binding)
ES297297A1 (en) A procedure for the production of a measles virus vaccine (Machine-translation by Google Translate, not legally binding)
ES390603A1 (en) Vaccine
ES301232A1 (en) Procedure for obtaining a vaccine against glosopeda. (Machine-translation by Google Translate, not legally binding)
ES267784A1 (en) Procedure for obtaining a live vaccine against glosopeda (Machine-translation by Google Translate, not legally binding)
ES342709A1 (en) A procedure for preparing an inactivated pork vaccine for the colera. (Machine-translation by Google Translate, not legally binding)
ES330274A1 (en) Procedure to prepare a vaccine against mumps. (Machine-translation by Google Translate, not legally binding)
ES220787A1 (en) A procedure for the elaboration of a vaccine against swine fever (Machine-translation by Google Translate, not legally binding)
ES328757A3 (en) A procedure for the production of a attenuated vaccine to immunize the pigs against the colera. (Machine-translation by Google Translate, not legally binding)
ES235398A1 (en) Procedure to produce a vaccine against the polyomelitis virus. (Machine-translation by Google Translate, not legally binding)
ES287963A2 (en) Procedure for obtaining a live vaccine against glosopeda (Machine-translation by Google Translate, not legally binding)